Home

Zlata Pojdi v službo namen overall survival ustnica nekje prevesti

Cureus | Analysis of Overall Survival in Patients With Multiple Primary  Malignancies: A Single-center Experience | Article
Cureus | Analysis of Overall Survival in Patients With Multiple Primary Malignancies: A Single-center Experience | Article

Overall survival of patients with EGFR mutation-positive non-small-cell  lung cancer treated with erlotinib, gefitinib or afatinib under drug  programmes in Poland – real-world data
Overall survival of patients with EGFR mutation-positive non-small-cell lung cancer treated with erlotinib, gefitinib or afatinib under drug programmes in Poland – real-world data

Long-term follow-up of overall survival for cabozantinib versus everolimus  in advanced renal cell carcinoma | British Journal of Cancer
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer

Overall Survival Data: Primary & Exploratory 5-Year Landmark Analysis -  ALECENSA® (alectinib)
Overall Survival Data: Primary & Exploratory 5-Year Landmark Analysis - ALECENSA® (alectinib)

A prognostic nomogram for overall survival in male breast cancer with  histology of infiltrating duct carcinoma after surgery [PeerJ]
A prognostic nomogram for overall survival in male breast cancer with histology of infiltrating duct carcinoma after surgery [PeerJ]

Kaplan-Meier curves for overall survival.
Kaplan-Meier curves for overall survival.

IMFINZI® (durvalumab) Efficacy & Clinical Trials for ES-SCLC
IMFINZI® (durvalumab) Efficacy & Clinical Trials for ES-SCLC

Overall survival and objective response in advanced unresectable  hepatocellular carcinoma: A subanalysis of the REFLECT study - Journal of  Hepatology
Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study - Journal of Hepatology

Updated Overall Survival in a Randomized Study Comparing Dacomitinib with  Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell  Lung Cancer and EGFR-Activating Mutations | SpringerLink
Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations | SpringerLink

Overall Survival | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Overall Survival | ENHERTU® (fam-trastuzumab deruxtecan-nxki)

Cancers | Free Full-Text | Progression-Free Survival and Overall Survival  in Patients with Advanced HER2-Positive Breast Cancer Treated with  Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
Cancers | Free Full-Text | Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab

LENVIMA® (lenvatinib) HCP Website | Overall Survival (OS)
LENVIMA® (lenvatinib) HCP Website | Overall Survival (OS)

Overall survival plot. Kaplan–Meier curve is shown for overall survival...  | Download Scientific Diagram
Overall survival plot. Kaplan–Meier curve is shown for overall survival... | Download Scientific Diagram

Cancers | Free Full-Text | Role of Postoperative Complications in Overall  Survival after Radical Resection for Gastric Cancer: A Retrospective  Single-Center Analysis of 1107 Patients
Cancers | Free Full-Text | Role of Postoperative Complications in Overall Survival after Radical Resection for Gastric Cancer: A Retrospective Single-Center Analysis of 1107 Patients

Efficacy of KISQALI® (ribociclib) + AI in Postmenopausal | HCP
Efficacy of KISQALI® (ribociclib) + AI in Postmenopausal | HCP

Circulating inflammation signature predicts overall survival and  relapse-free survival in metastatic colorectal cancer | British Journal of  Cancer
Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer | British Journal of Cancer

Overall Survival in Patients with PD-1 Inhibitor-related Inflammatory  Arthritis and Metastatic Melanoma - ACR Meeting Abstracts
Overall Survival in Patients with PD-1 Inhibitor-related Inflammatory Arthritis and Metastatic Melanoma - ACR Meeting Abstracts

Real-world time trends in overall survival, treatments and patient  characteristics in HR+/HER2− metastatic breast cancer: an observational  study of the SONABRE Registry - The Lancet Regional Health – Europe
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - The Lancet Regional Health – Europe

562 Overall survival rates and progression free survival in IDS vs PDS in  advanced ovarian cancer patients in the university hospitals of Leicester |  International Journal of Gynecologic Cancer
562 Overall survival rates and progression free survival in IDS vs PDS in advanced ovarian cancer patients in the university hospitals of Leicester | International Journal of Gynecologic Cancer

Metastatic behavior and overall survival according to breast cancer  subtypes in stage IV inflammatory breast cancer | Breast Cancer Research |  Full Text
Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer | Breast Cancer Research | Full Text

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer |  NEJM
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM

Median Overall Survival (mOS) | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Median Overall Survival (mOS) | ENHERTU® (fam-trastuzumab deruxtecan-nxki)

Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in  Stage III NSCLC—Update from PACIFIC - Journal of Thoracic Oncology
Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC - Journal of Thoracic Oncology

REVEL Trial Overall Survival for | CYRAMZA® (ramucirumab)
REVEL Trial Overall Survival for | CYRAMZA® (ramucirumab)

Overall Survival. Kaplan-Meier estimates of overall survival in... |  Download Scientific Diagram
Overall Survival. Kaplan-Meier estimates of overall survival in... | Download Scientific Diagram